Document Detail


Prolactinoma in pregnancy.
MedLine Citation:
PMID:  22115164     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Prolactinomas commonly cause infertility and treatment usually restores ovulation and fertility. The dopamine agonists are the preferred mode of treatment, with cabergoline generally being preferred to bromocriptine because of its higher therapeutic ratio. Experience with both drugs shows no increase in spontaneous abortions, preterm deliveries, multiple births, or congenital malformations, compared to what is expected in the normal population but the experience with bromocriptine is approximately 10-fold greater than with cabergoline. Clinically significant tumor growth may occur in 2.7% of those with microadenomas, 22.9% in those with macroadenomas without prior ablative treatment and 4.8% of those with macroadenomas with prior ablative treatment. Patients with macroadenomas should have visual fields assessed periodically during gestation. Should symptomatic tumor growth occur, reinstitution of the dopamine agonist is usually successful in shrinking the tumor but delivery if the pregnancy is sufficiently advanced is also an option and transsphenoidal debulking is rarely necessary.
Authors:
Mark E Molitch
Related Documents :
2351504 - Changes in fertility and the acceptability of pregnancies in northern finland during th...
626254 - Effects of social disincentive policies on fertility behavior in singapore.
7586864 - The black hole in charley toorop's "the three generations": a neuro-iconographic analys...
9704304 - Evaluation of a pregnancy-testing protocol in adolescents undergoing surgery.
9031374 - Antiphospholipid antibodies in healthy pregnant women.
3799154 - Alteration in sulfobromphthalein hepatic storage capacity (s) in non-pregnant women pre...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Best practice & research. Clinical endocrinology & metabolism     Volume:  25     ISSN:  1878-1594     ISO Abbreviation:  Best Pract. Res. Clin. Endocrinol. Metab.     Publication Date:  2011 Dec 
Date Detail:
Created Date:  2011-11-25     Completed Date:  2012-03-19     Revised Date:  2013-05-28    
Medline Journal Info:
Nlm Unique ID:  101120682     Medline TA:  Best Pract Res Clin Endocrinol Metab     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  885-96     Citation Subset:  IM    
Copyright Information:
Copyright © 2011 Elsevier Ltd. All rights reserved.
Affiliation:
Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. molitch@northwestern.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Bromocriptine / therapeutic use*
Dopamine Agonists / therapeutic use
Ergolines / therapeutic use*
Female
Fetus / drug effects
Humans
Hyperprolactinemia / complications,  drug therapy
Infertility, Female / etiology
Pregnancy
Pregnancy Complications, Neoplastic / drug therapy*
Prolactinoma / complications,  drug therapy*,  pathology
Chemical
Reg. No./Substance:
0/Dopamine Agonists; 0/Ergolines; 25614-03-3/Bromocriptine; LL60K9J05T/cabergoline

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Endocrine disorders in pregnancy: physiological and hormonal aspects of pregnancy.
Next Document:  Pregnancy and other pituitary disorders (including GH deficiency).